期刊文献+

他汀类药物在冠心病治疗中的应用探讨 被引量:5

Application of Statins in the Treatment of Coronary Heart Disease
下载PDF
导出
摘要 目的分析他汀类药物在冠心病治疗中的应用效果。方法选择我院自2016年3月—2017年3月收治的冠心病患者82例作为研究对象。依据治疗方法差异性,将其均分为两组。接受常规治疗方案的41例患者为参照组,接受阿托伐他汀治疗的41例患者为研究组,对两组冠心病患者的治疗效果进行总结。结果通过实施不同方法治疗,研究组患者的血脂下降情况优于参照组,组间对比,差异具有统计学意义(P<0.05)。研究组患者的不良事件发生率(2.4%)低于参照组(17.1%),组间对比,差异具有统计学意义(P<0.05)。结论在冠心病治疗中应用他汀类药物,可以使患者的血脂有效改善,使冠脉粥样斑块更加稳定。 Objective To analyze the effect of statins in the treatment of coronary heart disease. Methods 82 patients with coronary heart disease who were treated in our hospital from March 2016 to March 2017 were divided into two groups according to the difference of treatment. 41 patients with routine treatment regimen were treated with atorvastatin and 41 patients treated with atorvastatin were enrolled in this study. Finally, the treatment of coronary heart disease was summarized. Results By applying different methods of treatment, the blood lipid decline in the study group was better than that in the reference group, the difference between the two groups was statistically significant (P〈0.05). The incidence of adverse events in the study group (2.4%) was lower than that in the reference group (17.1%), the difference between the two groups was statistically significant (P〈0.05). Conclusion The application of statins in the treatment of coronary heart disease can improve the blood lipid of the patients, make the coronary plaque more stable.
作者 王红梅 WANG Hongmei(Electrocardiographic Room, Hechuan District People's Hospital of Chongqing City, Chongqing 401250, China)
出处 《中国继续医学教育》 2017年第17期170-171,共2页 China Continuing Medical Education
关键词 他汀类药物 冠心病 效果分析 statins coronary heart disease effect analysis
  • 相关文献

参考文献9

二级参考文献101

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2058
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2139
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5224
  • 4武阳丰,赵冬,周北凡,王薇,李贤,刘静,李莹,孙佳艺,赵连成,吴兆苏,诸骏仁.中国成人血脂异常诊断和危险分层方案的研究[J].中华心血管病杂志,2007,35(5):428-433. 被引量:175
  • 5Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial. Lancet,2002,360 : 7-22.
  • 6Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in ld randomised trials of statins. Lancet,2005, 366 : 1267-1278.
  • 7Smith SC Jr,Allen J,Blair SN ,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease : 2006 update. Circulat on, 2006,113:2363-2372.
  • 8Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III:a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prey Rehabil,2009,16 : 121-137.
  • 9Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease ( PROSPER ) : a randomised controlled trial. Lancet,2002,360 : 1623-1630.
  • 10Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med,2006,355: 549-559.

共引文献379

同被引文献35

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部